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BACKGROUND: Over the past decade, cardiovascular diseases 
have been recognized as the leading cause of mortality worldwide. 
Myocardial infarction (MI) is one of the most prevalent types of 
cardiovascular diseases that is caused by the closure of coronary 
arteries and ischemic heart muscle. Numerous studies have 
analyzed the role of H. pylori as a possible risk factor for coronary 
artery diseases, in most of which the role of infection in coronary 
artery disease is not statistically significant. 
METHODS: These contradictory findings made us conduct a 
systematic review to analyze all relevant studies in Iran through a 
meta-analysis and report a comprehensive and integrated result. 
All published studies from September 2000 until September 
2016were considered  
. Using reliable Latin databases like PubMed, Google Scholar, 
Google search, Scopus, Science Direct and Persian databases like 
SID, Irandoc, Iran Mede and Magiran. After quality control, these 
studies were entered into a meta-analysis by using the random 
effects model. After evaluating 
the studies, 11 papers were finally selected and assessed.  
RESULTS: A total of 2517 participants had been evaluated in these 
studies, including 1253 cases and 1264 controls. Based on the 
results of meta-analysis and using random effects model, an overall 
estimate of 
OR Helicobacter Pylori with Presence of Myocardial Infarction 
in Iran was OR=2.53 (CI=1.37-4.67). 
CONCLUSIONS: The results of this review study show that H. 
pylori are associated with the incidence of MI so that the odds ratio 
of MI in the patients with helicobacter pylori is twice greater than 
that of the people without H. pylori. Future studies are 
recommended to evaluate the mechanisms associated with relation 
of H. pylori with MI as well as its association with time.  
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Over the past decade, cardiovascular diseases have 
been recognized as the leading cause of mortality 
worldwide. These diseases caused the death of 16 
million people (30%) and made 293 million 
people (11%) disabled in 2010 (1,2). The same as 
many high-income developed countries over the 
past century, the low- and middle-income 
countries currently seem to be at the risk of an 
increased rate of cardiovascular diseases (3).  
Myocardial infarction (MI) is one of the most 
prevalent types of cardiovascular diseases that is 
caused by the closure of coronary arteries and 
ischemic heart muscle (4). Atherosclerosis is a 
chronic process with various reasons which cause 
the formation of plaque on the walls of coronary 
arteries over the years. Accumulation of 
lipoproteins and oxidation and non-enzymatic 
glycation changes cause the gradual development 
and enlargement of plaque. On the other hand, 
accumulation of phagocytes and macrophages and 
migration of smooth muscle cells in an 
inflammatory process cause the development of 
atherosclerosis. Atherosclerosis plaque injury 
activates the trombogenesis process, forming a 
clot on the walls at the lesion site and blocking the 
coronary artery. Accumulation of plaques and 
release of thromboxane A2, potent retractors, 
cause a complete arterial blockage (3,5).  
In the United States, one is afflicted with MI 
every 20 seconds, one dies due to MI every minute 
and about 50% of patients require rehabilitation 
and other measures following MI (6). According 
to the reports of the Ministry of Health and 
Medical Education in 2010, MI was recognized as 
the cause of 38% of mortalities. In recent years, 
the age of heart attack has dropped, affecting the 
young people too (7).   
Many risk factors such as old age, male 
gender, family history of early atherosclerosis, 
hyperlipidemia, hypertension, diabetes, smoking 
and obesity have been identified as causes of 
myocardial infarction (8). Further, evidence has 
been found to show the association of 
inflammatory indicators like CRP and fibrinogen 
with the risk of coronary artery diseases (9).  
Infection has been proposed to be involved in the 
incidence of atherosclerosis in recent years (6). 
Bacteria such as helicobacter pylori (H. pylori) 
and chlamydia pneumonia and viruses like 
cytomegalovirus and herpes have also been found 
to be involved in the incidence of atherosclerosis 
(8). Studies have shown that although infectious 
factors are not directly involved in the incidence 
of atherosclerosis, they stimulate the inflammatory 
response of atherosclerosis development and 
facilitate its complications (10).  
Helicobacter pylori are one of the most 
common human infections, and half of the world 
population is suffering from this infection. H. 
pylori have been recognized as the leading cause 
of several diseases of the upper digestive system 
since 1984. The incidence of H. pylori is much 
variable from 15% to 85%. It has been reported to 
be 20-50% in the developed countries and over 
80% in the developing countries (11,12). More 
than 80% of adults in Japan and Southern America 
are suffering from this infection, while this rate 
has been reported to be 40% in the U.K and 20% 
in Scandinavian countries (12). The incidence of 
H. pylori in Iran is more than 80%. Although it 
seems that it declined in the recent years, its 
incidence is still very high (13).   
Numerous studies have analyzed the role of 
H. pylori as a possible risk factor for coronary 
artery diseases, in most of which the role of 
infection in coronary artery disease is not 
statistically significant. Mandell et al. were the 
first to study the association of H. pylori with 
incidence of coronary heart disease (CHD) in 
1994 (14). These studies have reported various 
results; some have shown a strong correlation, 
some a weak correlation and some lack of 
correlation between H. pylori and MI diseases. 
These contradictory findings made us conduct a 
systematic review to analyze all relevant studies in 
Iran through a meta-analysis and report a 
comprehensive and integrated result.  Since there 
are different studies with different results in 
Iranian population and there was not any 
comprehensive study in this field to support a 
definite relationship between helicobacter pylori 
infection and MI, the present study aimed to 
determine the association of Helicobacter Pylori 
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with MI Iranian population during September 




In this research, the case-control studies were used 
to discover the association of H. pylori with MI. 
All English and Persian articles published from 
September 2000 to September 2016 were selected 
for analysis. The case group consisted of patients 
with MI and control group included participants 
without MI.  
Inclusion criteria: They comprised of the case-
control and cohort studies reporting the odds ratio 
of MI due to H. pylori in Iran or providing the 
possibility of its calculation using the frequency of 
MI.  
Exclusion criteria: They consisted of ecologic 
and cross-sectional studies and those not reporting 
H. pylori’s corresponding odds ratio (OR) and 
confidence interval (CI) 95% or not providing the 
possibility of its computation. 
  Searching strategy: The articles published in six 
valid Latin databanks, including Google Scholar, 
Cochrane, PubMed, Scopus and Science Direct 
and three Persian databanks, including SID, 
IranMedex and Magiran were extracted. The 
articles were searched using the following 
keywords in Farsi and English “Helicobacter 
Pylori [MeSH Terms],” “Helicobacter pylori 
[Title/Abstract],” “H. pylori [Title/Abstract],” 
“Coronary Disease [MeSH Terms],” “Myocardial 
infarction [Title/Abstract],” “Myocardial 
Infarction [MeSH Terms],”  “, Iran” and their 
combinations. 
 To ensure the correct selection of artciles 
related to the research topic, two researchers were 
required to search the articles. In searching the 
electronic databanks, all artciles were first 
extracted and the repetitive ones were excluded. If 
an article was repeated more than once, the article 
with the highest number of cases was chosen. 
Next, considering the inclusion and exclusion 
criteria, all the titles and abstracts and then full 
texts were checked and the relevant papers were 
selected for analysis.   
All papers were assessed by experts. The data 
collection and critical quality evaluation of articles 
were separately done by two researchers (A. Sh 
and M.B). After the critical evaluation, the 
selected articles were checked by both authors. 
 
Data extraction: After evaluating the quality of 
articles, the data of all the articles selected for 
analysis were extracted by a pre-prepared 
checklist. In the checklist for data extraction in the 
Excel software, the corresponding author’s 
surname, publication year, research location, age 
or mean age of participants, gender, sample size, 
number of cases, number of controls and OR (95% 
CI) were extracted. In studies that provided 
measurements for both H. pylori IgG and IgA, we 
extracted the information using IgG as a 
measurement of H. pylori infection. 
The extracted data were imported into Excel 
software and analyzed by Stata-12 software. 
Considering the results obtained from the 
heterogeneity of the studies (using Cochrane’s Q-
test and Higgins and Thompson’s I
2
), the fixed and 
random effect statistical models (95% CI) were 
applied for data analysis using metan command. 
Funnel plot was used to evaluate the publication 
bias, and Egger and Begg tests were used to 




The numbers of 11 case-control studies in 
different areas of Iran were included during 2001-
2015. A total of 2517 participants had been 
evaluated in these studies, including 1253 cases 
and 1264 controls. The mean age and standard 
deviation were found to be 56.57±3.47 in the case 
group and 54.55±3.73 in the control group. Also, 
from among all participants, there were 655 males 
and 401 females in the case group and 612 males 
and 435 females in the control group (Table 1).  
Among various studies, the minimum (OR= 
0.56, CI=0.21, 1.46) and maximum (OR=13.2, 
CI= 5.1, 34.3) ORs were reported by Raygan et al 
(2006) and Sarrafzade et al (2001), respectively 
(Table 2). Based on the results of meta-analysis 
and using random effects model, an overall 
estimate of OR=2.53 (CI=1.37-4.67) was reported 
for the exposure effect and H. pylori infection and 
suffering from MI (Table 2).  
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Table1: Characteristics of included studies  
 
 
Authors' names Province Publication year case control 
Jafarzadeh et al (15) Rafsanjan 2010 60 60 
Honarmand et al(16) Rasht 2012             100 76 
Bazzazi  et al (17) Gorgan 2009 70 70 
Sarrafzade et al(18) Isfahan 2008 57 44 
Sarrafzade et al (19) Isfahan 2001 52 55 
Dehghan et al (20) Qazvin                           2015   90  90 
Jalali et al (21) Babol                           2003 97 141 
Azarkar et al (22) Birjand 2011 73 78 
Khodaiet al (23) Tehran 2010 500 500 
Rahnema et al (24) Tabriz    2001 104 100 
Raygan  et al (25) Kashan 2006 50 50 
 
Table2: Pooled results for 11 case-control studies 
 
           Study      OR           [95% Conf. Interval]   % Weight 
A. Jafarzadeh (2010) 4.64 (1.88,   11.47) 8.79 
H. Honarmand (2012) 2.02        (0.96,    4.28)          9.35 
H.Bazzazi (2009)   3.03        (1.38,   6.66)           9.22 
N. Sarrafzade (2008) 0.83 (0.219,   3.14)           7.19 
N. Sarrafzade (2001) 13.22 (5.1 ,  34.3)        8.61 
N.Dehghan (2015) 2.579        (0.94,  7.5)         8.41 
F .Jalali (2003)       0.951        (0.57,  1.6)         10.09 
Z.Azarka (2011) 1.788        (0.9,  3.6)          9.53 
Z.Khodai (2010) 7.765        (5.83,   10.34)         10.61 
B.Rahnema (2001)     3.400        (1.73,   6.7)         9.59 
F.Raygan (2006) 0.564        (0.22,   1.46)          8.62 
D+L pooled OR         2.528        (1.37  ,   4.67) 100.00 
Heterogeneity chi-squared =  86.59 (d.f. = 10) p = 0.000; I-squared (variation in OR attributable to heterogeneity) =  
88.5%; Estimate of between-study variance Tau-squared =  0.9003; Test of OR=1: z=   2.97 p = 0.003 
 
The odds ratios were extracted from various 
studies according to the number of exposures in 
the case and control groups. The fixed and random 
effects models were applied. To detect 
homogeneity (Cochran’s Q-test, Higgins and 
Thompson’s I
2
) was applied. The heterogeneity 
test was used to evaluate the null hypothesis, and 
all studies were assessed for the similar effect. The 
effect of heterogeneity was estimated by I
2
 square, 
which provides a measurement of contradiction 
between studies and determines whether the total 
percentage of changes within the studies is due to 
heterogeneity. Also, 50<I
2
 indicates lack of 
homogeneity between studies. In this study, 
considering the heterogeneity index I
2
=88.5% and 
p<0.001, the random effect and Der Simonian and 
Laird methods were used. The mixed OR=2.53 
(CI=1.37-4.67) indicates that the odds ratio of MI 
in the patients with H. pylori was more than that 
of the control group or the people without H. 
pylori (p=0.001) (Figure 1). Begg’s test suggested 
no significant publication bias among the studies 
included in the analysis (all p > 0.05) (Figure 2). 
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Figure 1: Forest plot for odds ratio 
 
 




The association between H. pylori and MI has not 
been documented yet. This study is the first 
systematic review aiming to analyze the 
association of helicobacter pylori with MI in Iran. 
The results of the study showed that the OR of MI 
in case groups with helicobacter pylori 
infection was higher than that of the control 
group without the infection. Total OR in the 
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patients with H. pylori was found to be 2.5 times 
greater than those without this infection, which is 
indicative of the association of H. pylori with MI.  
The results of a systematic review carried out 
to analyze the association between H. pylori and 
MI indicated that from among the articles found, 
the odds ratio of MI in the patients with H. pylori 
was 1.73 times more than that of the participants 
without MI. However, this amount was reported to 
be 2.1 times following the exclusion of the papers 
with poor quality, which is to a large extent in line 
with the findings of this study. Nevertheless, in 
this study, the odds ratio of MI in patients with H. 
pylori in the Asian countries was 1.75 times 
greater than that of control group, indicating the 
higher chance of exposure to helicobacter pylori 
among the Iranian people than in some Asian 
countries (26). Moreover, a study in India showed 
that patients with H. pylori suffered from MI 2.5 
times more than those without H. pylori, which is 
in agreement with the findings of this study (27). 
Also, several studies reported the association of 
helicobacter pylori with MI, showing a higher 
level of infection in case groups than in control 
groups (28-31).     
Although a significant association was 
reported between H. pylori and MI in the above 
studies, some of them rejected this relation, 
reporting a low incidence for H. pylori. Nakic et 
al. reported the incidence rates of 29% vs. 26% for 
H. pylori in the case and control groups (32), 
while Kurshid et al. reported the incidence rates of 
45% vs. 47% (33). Moreover, Tsai et al. showed 
the incidence rates of 69% vs. 72% (34), 
indicating no statistically significant difference. In 
some studies like Kahan et al., despite the 
significant association between H. pylori and MI, 
the association was not much strong (OR=1.36 
and CI=1.02-1.82) (35). The contradiction 
regarding the presence or lack of relationship 
between H. pylori and MI was also evident in 
cohort studies. A meta-analysis performed on 
cohort studies showed no positive association 
between H. pylori and coronary artery diseases 
such as MI (36). However, another recent meta-
analysis on cohort studies indicated a significant 
increase (15%) for the Risk of coronary artery 
diseases (37).   
The significant association of H. pylori with the 
risk of MI can be explained in two ways. First, in 
the study of Reszka et al. carried out on patients 
with ischemic heart disease, the deoxyribonucleic 
acid of H. pylori was found in the aortic tissue and 
atherosclerotic plaque of the patients. This result 
can be indicative of the direct role of bacteria in 
the pathogenesis of ischemic heart disease and 
consequently MI (38). Secondly, this infection 
may reduce the HDL cholesterol and increase 
triglyceride level. Furthermore, coagulation 
parameters and other inflammatory factors like 
fibrinogen, prothrombin fragments, tumor necrosis 
factor and interleukin 6 and 8 may increase at 
serum level. These factors may play a role in the 
correlation of H. pylori with ischemic diseases 
(39). On the other hand, H. pylorus is not an 
independent factor involved in causing the disease 
in most of the cases; it can play an independent 
role along with such risk factors as diabetes, 
hypertension and smoking (32). Some studies 
have shown the association of H. pylori with low 
socioeconomic level. The incidence of coronary 
artery diseases and H. pylori can be due to close 
correlation of these diseases with socioeconomic 
status of people (19). Hence, better results can be 
obtained regarding the correlation of H. pylori 
with MI by controlling the confounding factors.  
The strength of this study is that it is, to the 
best of the researchers’ knowledge, the first study 
to comprehensively evaluate the correlation of H. 
pylori with MI in Iran. Also, few studies have 
addressed this issue via meta-analysis worldwide.   
The results of the study show that H. pylori 
are associated with the incidence of MI so that the 
odds ratio of MI in patients with helicobacter 
pylori is twice greater than that of the people 
without H. pylori. Future studies are 
recommended to evaluate the mechanisms 
associated with relation of H. pylori with MI as 
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